The AIM urged the government of India to compensate all the victims of COVID-19 vaccines, including their family members, through a mechanism that also involves vaccine manufacturers.

AstraZeneca, a British pharmaceutical company, has admitted in a UK court that its vaccine, which is sold in India under the name Covishield, can cause a rare side effect related to blood clotting called TTS.

Prime Minister Narendra Modi flagged off India’s mass Covid-19 vaccination drive with two vaccines - Serum Institute of India’s (SII) Covishield and Bharat Biotech’s homegrown vaccine Covaxin - which were approved by the country's drugs regulator earlier in January 2021.